Equity-Based Compensation (Tables)

9 Months Ended

Sep. 29, 2012

Compensation Expense And Related Tax Benefit For Equity-Based Payments

	Three Months Ended				Nine Months Ended
	September 29, 2012		October 1, 2011		September 29, 2012		October 1, 2011
Cost of sales	$	287	$	218	$	820	$	755
Selling and marketing		511		333		1,271		1,107
Research and development		374		343		1,196		1,037
General and administrative		2,268		2,204		8,198		7,149
Total compensation	$	3,440	$	3,098	$	11,485	$	10,048
Income tax benefit	$	1,217	$	1,069	$	4,003	$	3,467

Weighted-Average Assumptions Used For Grants Of Stock Options And SARs

	Nine Months Ended
	September 29, 2012			October 1, 2011
Expected dividend yield		0	%		0	%
Forfeiture rate		10.21	%		11.50	%
Volatility		35.90	%		35.33	%
Risk free interest rate		.94	%		2.01	%
Range of interest rates		0.07% - 1.95	%		0.01% - 3.18	%
Expected weighted-average life		5.48 years			5.42 years
Fair value of stock appreciation rights (SARs) granted	$	5,507,000		$	5,495,000
Weighted-average grant date fair value of SARs granted	$	12.84		$	14.29

Summary of SAR Activity

	Nine Months Ended September 29, 2012
SARs	Shares			Weighted-Average Exercise Price
Outstanding at beginning of year		1,287,724		$	28.91
Granted		428,987			38.51
Exercised		(64,582	)		23.05
Forfeited		(35,725	)		34.30
Expired		(2,011)			41.57
Outstanding at end of period		1,614,393		$	31.56
Exercisable at end of period		553,996		$	26.48
Intrinsic value of exercised SARs	$	953,020

Summary Of Outstanding And Exercisable Options

The following table summarizes information about stock options outstanding at September 29, 2012:

	Outstanding						Exercisable
Range of Exercise Prices	Number of Shares		Weighted-Average Remaining Contractual Life		Weighted-Average Exercise Price		Number of Shares		Weighted-Average Exercise Price
$ 1.29-$36.49		422,223		4.78 years	$	32.84		416,537	$	33.02
$ 36.80-$41.25		378,221		4.56 years		39.78		378,221		39.78
$ 42.28-$45.62		401,316		2.99 years		44.51		401,316		44.51
$ 46.18-$51.62		374,856		2.20 years		48.63		374,856		48.63
$ 53.92-$53.92		1,800		1.66 years		53.92		1,800		53.92
		1,578,416						1,572,730

	Outstanding		Exercisable
Aggregate intrinsic value	$	1,744,000	$1,643,000
Weighted-average remaining contractual term		3.7 years	3.7 years

Summary Of Stock Option Activity

	Nine Months Ended September 29, 2012
Options	Shares			Weighted-Average Exercise Price
Outstanding at beginning of year		1,702,650		$	40.43
Granted		0			0.00
Exercised		(102,230	)		27.26
Forfeited		(1,663	)		36.36
Expired		(20,341	)		43.63
Outstanding at end of period		1,578,416		$	41.24
Exercisable at end of period		1,572,730		$	41.32
Intrinsic value of exercised options	$	1,090,858

Summary Of Restricted Stock Award Activity

	Nine Months Ended September 29, 2012
Restricted Stock Awards	Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		836,141		$	28.34
Granted		235,889			38.53
Released		(226,978	)		20.93
Forfeited		(113,640	)		23.26
Outstanding at end of period		731,412		$	34.72

Summary Of Awards Granted Under Equity-Based Compensation Plans

	As of September 29, 2012
Awards granted under Zebra’s equity based compensation plans:
Unearned compensation costs related to awards granted	$	21,978,000
Period expected to be recognized over		2.6 years

Weighted-Average Assumptions Used For Employee Purchase Rights Granted Under Stock Purchase Plan

	Nine Months Ended
	September 29, 2012			October 1, 2011
Fair market value	$	34.93		$	35.86
Option price	$	33.18		$	34.07
Expected dividend yield		0	%		0	%
Expected volatility		21	%		32	%
Risk free interest rate		0.06	%		0.09	%

Stock Appreciation Rights (SARs) [Member]

Summary Of Outstanding And Exercisable Options

The following table summarizes information about SARs outstanding at September 29, 2012:

	Outstanding						Exercisable
Range of Exercise Prices	Number of Shares		Weighted-Average Remaining Contractual Life		Weighted-Average Exercise Price		Number of Shares		Weighted-Average Exercise Price
$ 19.56-$19.56		368,856		6.60 years	$	19.56		256,826	$	19.56
$ 21.83-$27.50		56,764		7.10 years		24.82		46,761		24.64
$ 27.82-$27.82		400,461		7.60 years		27.82		127,518		27.82
$ 28.33-$37.15		61,725		9.02 years		33.37		25,976		34.82
$ 38.79-$42.36		726,587		9.12 years		40.09		96,915		41.69
		1,614,393						553,996

	Outstanding		Exercisable
Aggregate intrinsic value	$	10,972,000	$6,257,000
Weighted-average remaining contractual term		8.1 years	7.4 years